MedPath

Effect of Oral Midazolam and Ketamine in Pediatric Sedatio

Phase 3
Conditions
Pediatric Sedation.
Registration Number
IRCT20180717040509N2
Lead Sponsor
Sari University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
102
Inclusion Criteria

Pediatric between 2 to 10 years olds

Exclusion Criteria

Children with Upper Respiratory Tract Infection
Dissatisfaction to participate in the study
Grade 3, 4, 5 or 6 of American Anesthesiology Association (ASA)
Use of Sedative and Narcotic drugs
Prohibited for Sedation
Head Truama
History of Cardiovascular Disease
Eye Trauma
History of Central Nervous System (CNS)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sedation. Timepoint: Every 5 minutes to 40 minutes. Method of measurement: Ramsay Sedation Scale.;Pediatric's behavior. Timepoint: Every 5 minutes to 40 minutes. Method of measurement: Houpt Checklist.;Crying Rate. Timepoint: Every 5 minutes to 40 minutes. Method of measurement: Houpt Checklist.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath